1 The present experiments were designed to investigate the role of asymmetrical N G ,N G -dimethyl-Larginine (ADMA) in causing hypertension associated with the focal and segmental glomerulosclerosis (FSGS) produced by a single bolus of puromycin aminonucleoside (PAN) and successive injection of protamine for 7 days in rats which had undergone unilateral nephrectomy. 2 After the unilateral nephrectomy, and administering PAN and protamine, histological examinations of the kidney revealed a typical FSGS, that is, evident abnormalities including segmental mesangial proliferation, obliteration of glomerular capillary lumens and adhesions between the glomerulus and Bowman's capsule could be observed. Changes in the glomerular epithelial cells consisted of the swelling with bleb formation. 3 In the FSGS rats, urine volume and urinary protein were signi®cantly (P50.05 and P50.005) increased throughout 4-week experimental period, while the creatinine clearance was signi®cantly (P50.005) and transiently decreased, and recovered 4 weeks later. These changes were associated with the sustained elevation of the systolic blood pressure. 4 ADMA levels in aortic endothelial cells, plasma and urine were signi®cantly (P50.05 and P50.005) increased in the FSGS rats, but the level in the kidney remained unchanged. 5 The basal level and net production of cyclic GMP in the aortic vessel wall with endothelium when stimulated by norepinephrine and acetylcholine were signi®cantly (P50.05 and P50.01) attenuated in the FSGS rats. 6 There were signi®cant and positive correlations between systolic blood pressure (y) and ADMA levels (x) in endothelial cells (y=4.43x+122.2, r=0.979, P50.0001), plasma (y=0.10x+71.9, r=0.921, P50.001) and urine (y=0.48x+126.9, r=0.699, P50.005), but not signi®cant in the kidney (y=0.06x+102.7, r=0.252, NS). 7 These ®ndings suggest that ADMA as an endogenous inhibitor of NO synthesis may play an important role for the pathogenesis in the hypertension associated with the experimental FSGS in the rat.
Introduction
Experimental evidence had demonstrated that the L-arginine-NO pathway plays an important role for the maintenance of peripheral vascular tone. In humans, the infusion of N Gmonomethyl-L-arginine (L-NMMA) into the brachial artery signi®cantly reduced forearm blood¯ow (Vallance et al., 1989) . Recently, it has been reported that ADMA plays an important role for the pathogenesis of salt-sensitive hypertension (Matsuoka et al., 1997) . In addition, Vallance et al. (1992) have reported that accumulation of endogenous ADMA might contribute to the hypertension associated with chronic renal failure in human. However, details causing hypertension associated with renal impairment remain still obscure.
Focal and segmental glomerulosclerosis (FSGS) is believed to represent a pathologic pattern of a number of clinical renal disorders (Baldwin, 1982; Brenner et al., 1982) . Laboratory models also exist with glomerular abnormalities that are very similar to the human pathologic process. The administration of puromycin aminonucleoside (PAN) in unilaterally nephrectomized rats provides a well-characterized model of FSGS and interstitial ®brosis that results in the development of massive proteinuria and renal failure Velosa et al., 1977; Grond et al., 1984; Ebihara et al., 1993; Nakamura et al., 1993) . On the basis of these ®ndings, the present experiments were designed to investigate the role of ADMA in the pathogenesis of hypertension associated with the experimental FSGS in rats.
Methods

Preparation of the FSGS model
Male Sprague-Dawley rats, 10 weeks of age, were used. These rats were purchased at 6 weeks of age and housed in a temperature (23+18C)-and humidity (50+20%)-controlled room and were fed regular chow (CLEA Rodent Diet: CE-2, Japan CLEA, Tokyo, Japan) throughout the experimental periods. Systolic blood pressure and body weight were determined twice a week and once a week, respectively, from 2 weeks before to 4 weeks after starting the experiments. Animals were randomly divided into three groups of A, B and C, each consisting of 15 rats. Under ether anaesthesia and semisterile conditions, animals of groups B and C were subjected to the right unilateral nephrectomy via a midline incision of abdomen. demonstrated that the unilateral nephrectomy augmented proteinuria and markedly accelerated the development of FSGS in rats given PAN. On the day of nephrectomy, animals received either the injection of 0.4 ml of 0.9% saline 100 g 71 body weight (group B) or puromycin aminonucleoside (5 mg in 0.9% saline 100 g 71 body weight) (PAN; Wako Pure Chemicals, Tokyo, Japan) (group C) via the caudal vein (Week 0) according to Diamond & Karnovski (1986) who demonstrated that one-third of the usual dosage of PAN, when injected as a single intravenous bolus, resulted in the glomerular injury consistent with FSGS. Coincidentally with the intravenous PAN injection, rats in group C received intravenous daily dose of protamine sulphate (4.5 mg 0.1 ml 71 100 g 71 body weight) (Grade II from salmon, Sigma, St. Louis, MO, U.S.A.) for 7 days according to Saito et al., (1987) who have demonstrated that PAN-induced nephrosis is enhanced by the co-administration of protamine sulphate. Group A served as control without any operation and agent. Systolic blood pressure was determined in warmed conscious rats using the indirect tail cu method (Programmable Sphygmomanometer PS-100, Riken Kaihatsu, Tokyo, Japan). One, 2 and 4 weeks after the nephrectomy, urine volume, urinary protein excretion and creatinine clearance were determined from an overnight collection of urine using metabolic cages. During the collection period, rats were given free access to water and food. Blood samples were withdrawn via the jugular vein under ether anaesthesia. At week 1, 2 and 4, ®ve rats each were sacri®ced under ether anaesthesia. The left kidney was removed. The upper half of the left kidney was ®xed in a 10% neutral solution of formaldehyde for histological examinations. Remaining lower half was frozen for the determinations of ADMA, DNA and protein levels. This study complied with the Animal Welfare Regulations of Tokyo Medical and Dental University and the Guiding Principles for the Care and Use of Laboratory Animals approved by the Japanese Pharmacological Society.
Determination of ADMA and SDMA
In order to determine the ADMA and symmetrical N G ,N' G -dimethyl-L-arginine (SDMA) concentrations in endothelial cells and cyclic GMP production by the aortic vessel wall, additional 126 rats were divided into three groups corresponding to groups A (normal control without any treatment), B (uninephrectomized) and C which had undergone the unilateral nephrectomy and received PAN and protamine, each consisting of 42 rats. Twenty one rats from each group were sacri®ced under ether anaesthesia at week 1 and 4. Thoracic aorta was rapidly excised and kept in the cold Krebs solution. After removal of the fat and connective tissue, endothelial cells from seven rats each were collected from the luminal surface according to the method described previously (Azuma et al., 1995) and pooled for processing the determination of ADMA and SDMA, which was performed by means of automated high-performance liquid chromatography (HPLC) according to the method described previously (Azuma et al., 1995; Hamasaki et al., 1997) . Three determinations for each group were performed.
Determination of cyclic GMP
Ring preparations weighing approximately 8 mg with intact endothelium were cut o with razor blade from the thoracic aorta of each rat in groups A, B and C. The cyclic GMP level was determined according to the method described by Honma et al., (1977) and Rapoport & Murad (1983) with minor modi®cations. The preparations which had been processed without damaging luminal surface were preincubated in the modi®ed Krebs solution for 5 min at 378C, transferred into the fresh Krebs solution and followed by further 30 minincubation until preparations were rapidly transferred into 10% trichloroacetic acid (TCA) with liquid nitrogen in order to stop the reaction. (Kobayashi & Hattori, 1990) . The basal level was given as the value without any agonist and antagonist except for IBMX.
Determinations of DNA and protein
The microassay of DNA was performed according to thē uorometric method described by Kissane & Robins (1958) . Protein concentration was measured with bovine serum albumin as a standard by the method of Lowry et al., (1951) .
Histological examinations
The kidney specimens were embedded in paran after dehydration with ethanol. Thin sections were stained with hematoxylin eosin (HE) or periodic acid-Schi (PAS) reagent for light microscopic analysis.
Statistical analysis
Results are given as mean+s.e.m. The statistical analysis was carried out by a two-way analysis of variance (ANOVA). If the mean values were found to be dierent at P50.05 by ANOVA, Student's t-test was also applied. Correlation was examined by Pearson's correlation coecient (r) and Fischer's z-translation (analysis of the statistical signi®cance). Regression equation was obtained by the least square method.
Results
Body weight change
The mean body weight was determined to be 318.3+3.4 g for group A (n=15), 329.7+6.8 g for group B (n=15) and 331.1+6.6 g for group C (n=15) at week 0. These values were not signi®cantly dierent from each other. Similar time course of the body weight change was observed in group A (normal control without any treatment) and group B which underwent unilateral nephrectomy but did not receive PAN and protamine. One, 2 and 3 weeks after the unilateral nephrectomy, and the administration of PAN and protamine, the body weight gain was signi®cantly (P50.05 and P50.005) reduced in group C vs the corresponding value in groups A and B. However, there was no signi®cant dierence among three groups at week 4.
Changes in urine volume, urinary protein and creatinine clearance
Urine volume (ml 24 h 71 ), urinary protein (mg 24 h 71 ) and creatinine clearance (ml min 71 kg 71 body weight) were compared among three groups of A, B and C. There were no signi®cant dierences in the urine volume and urinary protein excretion between groups A and B (Figure 1, I and II). Creatinine clearance in group B tended to be decreased at week 1 and 4 or signi®cantly (P50.05) decreased at week 2 vs corresponding value in group A (Figure 1, III) . Urine volume and urinary protein in group C were, however, signi®cantly (P50.05 and P50.005) increased as compared to those values in group A or partially in group B throughout the experimental periods (Figure 1, I and II). In addition, the creatinine clearance in group C was signi®cantly (P50.005) lower than that in group A at week 1 and 2, and recovered to the control level 4 weeks later (Figure 1, III) . The value in group C at week 4 was signi®cantly (P50.005) higher than the corresponding value in group B.
Histological ®ndings
Figure 2 demonstrates histological changes 4 weeks after the unilateral nephrectomy, and the administration of PAN and protamine (group C). Evident abnormalities including segmental mesangial proliferation, obliteration of glomerular capillary lumens, and adhesions between the glomerulus and Bowman's capsule could be observed. Changes in the glomerular epithelial cells consisted of the swelling with bleb formation. Cellular crescent formation could be observed in the glomerulus. There were focal atrophy and a few proteinous cast formation in the uriniferous tubules, and diuse but slight in®ltration of small mononuclear cells in the interstitium. No abnormalities were observed in the kidneys of groups A and B.
Protein and DNA levels in the kidney
The protein and DNA levels (mg g 71 wet weight) in the kidney were compared among the three groups. Results are shown in Table 1 . Both of the protein and DNA levels in group C and the protein level in group B were signi®cantly increased as compared to the corresponding values in group A, suggesting the renal hypertrophy in group B, and the renal hypertrophy and increased mesangial proliferation in group C after the unilateral nephrectomy, and the administration of PAN and protamine. 
Changes in systolic blood pressure
The systolic blood pressure was determined twice a week. The values in groups A and B were ranged between 124.9+2.9 and 130.7+1.3 mmHg and were not dierent from each other throughout the experimental periods. In group C which had undergone the unilateral nephrectomy and received PAN and protamine, signi®cant (P50.005 vs groups A and B) elevation of the systolic blood pressure was noted during the periods after the treatments. The blood pressure in group C was determined to be 130.6+0.8 (n=15), 136.8+0.8 (n=15), 147.0+1.5 (n=10), 154.8+3.3 (n=5) and 153.2+4.5 (n=5) mmHg (n=5) at week 0, 1, 2, 3 and 4, respectively. These results are shown in Figure 3 .
ADMA levels in endothelial cells, plasma, urine and kidney, SDMA level in endothelial cells, and ADMA clearance
The ADMA and symmetrical N G , N' G ,-dimethyl-L-arginine (SDMA) concentrations in endothelial cells was calculated using the method described previously (Hamasaki et al., 1997) and compared between groups A, B and C ( (Table 2) . As shown in Figure 4 , I ± III, ADMA levels in plasma (pmoles ml 71 ) and urine (nmoles 24 h 71 urine) of group C were signi®cantly higher vs corresponding values in groups A and B. The levels in groups A and B were not dierent from each other except for the plasma ADMA in group B at week 2, which was signi®cantly dierent from corresponding value in group A. In addition, ADMA levels (pmoles mg 71 protein) in the kidney were not dierent from each other among three groups.
ADMA clearance was compared among groups A, B and C. 
Cyclic GMP production by the aortic vessel wall
The basal level and net production of cyclic GMP (pmole mg 71 protein) were compared among three groups. Not only basal level but also net production in groups A and B were not signi®cantly dierent and remained unchanged at weeks 1 and 4. By dosing PAN and protamine in unilaterally nephrectomized rats (group C), the basal level and net production of the nucleotide were signi®cantly (P50.05 and P50.01) attenuated in group C at weeks 1 and 4 vs corresponding values in groups A and/or B. These results are shown in Figure 5 .
Relationship between systolic blood pressure and ADMA levels Figure 6 , I ± IV shows the relationships between systolic blood pressure (y) and ADMA levels (x) in aortic endothelial cells, Figure 3 Changes in systolic blood pressure of groups A, B and C. Each point represents the mean value of 15 rats at * week 1, 10 rats at * week 2 and ®ve rats at * week 4. a :Signi®cant dierence vs corresponding values in groups A and B at P50.005. plasma, urine and kidney at week 4. There were positive and signi®cant correlations between systolic blood pressure and ADMA levels in endothelial cells (y=4.43x+122.2, r=0.979, P50.0001), plasma (y=0.10x+71.9, r=0.921, P50.001) and urine (y=0.48x+126.9, r=0.699, P50.005). However, the relations were not signi®cant in the kidney (y=0.06x+102.7, r=0.252, NS).
Discussion
Focal and segmental glomerulosclerosis (FSGS) is believed to represent a pathologic pattern of a number of clinical renal disorders (Baldwin, 1982; Brenner et al., 1982) . In the present experiments, the administration of PAN and protamine in unilaterally nephrectomized rats provided typical FSGS that resulted in the development of massive proteinuria and renal failure. Similar results were reported by other investigators Velosa et al., 1977; Grond et al., 1984; Ebihara et al., 1993; Nakamura et al., 1993) .
On the basis of these ®ndings, the role of asymmetrical N G , N G -dimethyl-L-arginine (ADMA) in the pathogenesis of hypertension associated with the experimental FSGS was investigated. ADMA levels in aortic endothelial cells, plasma and urine were signi®cantly increased in FSGS rats, but the level in the kidney remained unchanged. Experimental evidence has demonstrated that NO plays an important role in the maintenance of peripheral vascular tone. Selective inhibitors of NO synthase (NOS) such as N G -monomethyl-Larginine (L-NMMA) and ADMA can inhibit NO production Gross et al., 1990; Vallance et al., 1992) . These inhibitors have equally potent vasoconstrictor and pressor actions . In addition, the acute administration of L-NMMA produced an increase in the arterial blood pressure in guinea-pigs (Aisaka et al., 1989) , rabbits , dogs (Chu et al., 1990) and rats (Whittle et al., 1989; Tolins et al., 1990; Hecker et al., 1990) ; these were mostly due to an increase in total peripheral resistance (Gardiner et al., 1990) . Recently, Matsuoka et al., (1997) have provided evidence indicating that urinary ADMA excretion is signi®cantly correlated with arterial pressure in Dahl salt-sensitive hypertensive rats and suggested the role of ADMA as an endogenous NOS inhibitor in the pathogenesis of salt-sensitive hypertension. In the present experiments, it was demonstrated that there were signi®cant and positive correlations between systolic blood pressure and ADMA levels in endothelial cells, plasma and urine, although it may not be really legitimate to draw a correlation curve. These correlations may be important for understanding the pathogenesis of hypertension associated with FSGS.
The ADMA concentration in endothelial cells was determined to be 8.2 mM 4 weeks after PAN and protamine, of which concentration may at least partially inhibit NO synthesis, since the median inhibitory concentration (IC 50 ) of ADMA for the cyclic GMP production was 18.5 mM, and the inhibition in a concentration of 8.2 mM was calculated to be 40% in the rabbit carotid artery strips with intact endothelium (Azuma: unpublished observation) . In addition, the present experiments revealed that the net production of cyclic GMP in the aortic strips from FSGS rats was signi®cantly (P50.05) decreased (61.6% of the control), which would re¯ect the decreased NO biosynthesis and would be brought about by the accumulated ADMA in endothelial cells. It has been reported that native NO binds the heme group of soluble guanylate cyclase (Ignarro, 1990a) , stimulating the production of cyclic GMP. Consequently, several groups of investigators have used the generation of cyclic GMP as an index of NO biosynthesis Ignarro, 1990b; LuÈ scher et al., 1990) . Considering that endothelial cells are the major producers of NO in virtually all vascular territories, it would be logical to assume that the decreased NO production in endothelial cells resulting from the increased concentration of ADMA contributes to the increase in total peripheral resistance and to causing hypertension.
Mechanisms increasing ADMA levels in endothelial cells are not clari®ed in the present experiment, several possibilities are, however, considered. According to Bogle et al., (1995) , transmembrane transport of the endogenous methylarginines might alter their concentrations in endothelial cells. Therefore, it seems possible to assume that the administration of PAN and protamine may result in an increase in the incorporation of ADMA by endothelial cells, which, in turn, increases the intracellular concentration of the methylarginine and inhibits the NO biosynthesis. This speculation may be supported by the ®ndings that the ADMA concentration in endothelial cells was approximately 10 fold higher than that in the plasma 4 weeks after PAN and protamine (Figure 4, I and Table 2 ). However, further experiments will be necessary to con®rm this hypothesis. Dimethylarginine dimethylaminohydrolase (DDAH) as an enzyme that metabolizes ADMA is localized in endothelial cells and blood vessels (MacAllister et al., 1996) . The administration of PAN and protamine may inhibit the enzyme activity, resulting in a high level of ADMA in endothelial cells. This speculation may be supported in part by the ®ndings that the endothelial concentration of symmetrical N G , N' G ,-dimethyl-L-arginine (SDMA), which is not a substrate for DDAH (Ogawa et al., 1989) , remained unchanged in all groups examined in the present experiments. In addition to the inhibition of DDAH, measurements of the increased biosynthesis of ADMA in endothelial (Kobayashi & Hattori, 1990) . The basal level was given as the value without any agonist and antagonist except for IBMX (see text).
cells (Fickling et al., 1993) would be also helpful to reveal the mechanism increasing the inhibitor level. Details remain to be investigated.
Although the metabolic pathway of ADMA under the physiological conditions has been extensively investigated (Ogawa et al., 1987; Vallance et al., 1992; Fickling et al., 1993; Kimoto et al., 1993; , we have little information regarding the altered metabolism in the pathological conditions (Yu et al., 1994; Azuma et al., 1995; Bode-BoÈ ger et al., 1996) . ADMA is produced in several organs, released into blood and excreted from the kidney (Kakimoto & Akazawa, 1970; Ogawa et al., 1989; Kimoto et al., 1993 ). However, the plasma level and urinary excretion are mainly determined by the renal production and excretory capacity of ADMA (Ogawa et al., 1989; Vallance et al., 1992 ). Thus, it seems possible to assume that the increased plasma ADMA is due to the augmented renal functions to produce and that the increased urinary ADMA results from the increased renal excretion of ADMA in FSGS rats, in which ADMA clearance was signi®cantly increased even when creatinine clearance was decreased. However, the detailed reason why the decreased creatinine clearance was accompanied by the increased ADMA clearance remains unclari®ed in the present experiments. Since the ADMA level in the FSGS rat kidney was not increased, the increased renal production of ADMA may not be re¯ected on the increase in tissue level of the inhibitor.
In conclusion, our results suggest that ADMA may play a role for the pathogenesis of hypertension associated with Figure 6 Relationships between systolic blood pressure and asymmetrical N G , N G -dimethyl-L-arginine (ADMA) levels in endothelial cells (I), plasma (II), urine (III) and kidney (IV) at week 4. Correlation was examined by Pearson's correlation coecient (r) and Fischer's z-translation (analysis of the statistical signi®cance). Regression equation was obtained by least square method. In (I), 21 rats from each group were sacri®ced under ether anaesthesia at week 4. Endothelial cells of the thoracic aorta from seven rats each were collected from the luminal surface and pooled for processing the determination of ADMA. Three determinations for each group were performed. Systolic blood pressure of seven rats was averaged and demonstrated as three dierent points for each group in (I) (see text).
FSGS and that the increase in ADMA levels in endothelial cells, plasma and urine is not likely to be a secondary phenomenon in response to blood pressure elevation, since SHR had lower urinary ADMA excretion than WKY (Matsuoka et al., 1997) . However, a further assessment of the hypertensinogenic signi®cance of ADMA requires informations on the feasibility of chronically sustaining the elevation of blood pressure against the action of other compensatory mechanism.
